Invesco Biotechnology & Genome ETF
PBE
PBE
96 hedge funds and large institutions have $79.8M invested in Invesco Biotechnology & Genome ETF in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
96
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.61M | |
| 2 | +$466K | |
| 3 | +$413K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$258K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$231K |
Top Sellers
| 1 | -$2M | |
| 2 | -$418K | |
| 3 | -$349K | |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$240K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$240K |